Inducing compliance with postmarket studies for drugs under FDA's accelerated approval pathway
Year of publication: |
2021
|
---|---|
Authors: | Xu, Liang ; Zhao, Hui ; Petruzzi, Nicholas C. |
Published in: |
Manufacturing & service operations management : M & SOM. - Catonsville, MD : INFORMS, ISSN 1523-4614, ZDB-ID 2021015-2. - Vol. 23.2021, 1, p. 170-190
|
Subject: | health public policydrug approval policy | pharmaceutical industry | asymmetric informationmoral hazard | Pharmaindustrie | Pharmaceutical industry | Arzneimittel | Pharmaceuticals | Arzneimittelrecht | Pharmaceutical law |
-
Reverse drug distribution chain : analysis of the phenomenon
Bańska, Karolina, (2022)
-
Bargaining and international reference pricing in the pharmaceutical industry
Dubois, Pierre, (2022)
-
The Protectors : the story of the Food and Drug Administration
Neal, Harry Edward, (1968)
- More ...
-
Inducing Compliance with Post-Market Studies for Drugs Under FDA’s Accelerated Approval Pathway
Xu, Liang, (2019)
-
Inventory sharing and demand-side underweighting
Zhao, Hui, (2021)
-
'Not a Box of Nuts and Bolts' : Distribution Channels for Specialty Drugs
Xu, Liang, (2021)
- More ...